The World Health Organisation (WHO) has released a new report titled “2023 Antibacterial Agents In Clinical and Preclinical Development: An Overview and Analysis.” The report assesses the progress of new antibacterial drugs in relation to priority pathogens. This study is part of WHO’s efforts to address gaps in antibacterial drug development. The report provides an overview of the progress and potential of antibacterial drugs in tackling global health challenges.